USP Expands Support for Controlling Impurities in Medicines
yahoo.com
finance
2022-10-19 14:00:00

New Portfolio of Pharmaceutical Analytical Impurities Supports Drug R&D and Method Development

ROCKVILLE, Md., Oct. 19, 2022 /PRNewswire/ -- The U.S. Pharmacopeia (USP) has launched a new portfolio of impurities materials to support pharmaceutical manufacturers efforts to accelerate and strengthen analytical R&D and process development. USP Pharmaceutical Analytical Impurities (PAIs) support impurity analysis and profiling requirements during drug development and throughout the product lifecycle.
